All Stories

  1. Identification of potential inflammation markers for outgrowth of cow’s milk allergy
  2. A three-country analysis of the gut microbiome indicates taxon associations with diet vary by taxon resolution and population
  3. Targeting the Microbiota Reverses C‐Section‐Induced Effects on Intestinal Permeability, Microbiota Composition, and Amygdala Gene Expression in the Mouse
  4. Aberrant microbiota signatures precede symptom development in infantile colic
  5. Milk phospholipid-coated lipid droplets modulate the infant gut microbiota and metabolome influencing weight gain
  6. A randomized controlled study protocol of the TOBBI trial: the effect of a 6 weeks intervention with synbiotics on the recovery speed of the gut microbiota after antibiotic treatment in Dutch toddlers
  7. Restoration of gut microbiota with a specific synbiotic-containing infant formula in healthy Chinese infants born by cesarean section
  8. Characterization of Extracellular Vesicles from Streptococcus thermophilus 065 and Their Potential to Modulate the Immune Response
  9. Plant protein dominant enteral nutrition, containing soy and pea, is non-coagulating after gastric digestion in contrast to casein dominant enteral nutrition
  10. In vitro gastrointestinal lipid handling and bioaccessibility rate of infant formula with large phospholipid-coated lipid droplets are different from those of standard formula and closer to human milk
  11. A young child formula supplemented with a synbiotic mixture of scGOS/lcFOS and Bifidobacterium breve M-16V improves the gut microbiota and iron status in healthy toddlers
  12. A three-country analysis of the gut microbiome indicates taxon associations with diet vary by location and strain
  13. Longitudinal changes in bifidobacterial population during the first two years of life
  14. Resource sharing of an infant gut microbiota synthetic community in combinations of human milk oligosaccharides
  15. Trackability of proteins from probiotic Bifidobacterium spp. in the gut using metaproteomics
  16. A synbiotic mixture of selected oligosaccharides and bifidobacteria assists murine gut microbiota restoration following antibiotic challenge
  17. Assessment of infant outgrowth of cow’s milk allergy in relation to the faecal microbiome and metaproteome
  18. Early-life differences in the gut microbiota composition and functionality of infants at elevated likelihood of developing autism spectrum disorder
  19. Quantitative Physiology and Proteome Adaptations of Bifidobacterium breve NRBB57 at Near-Zero Growth Rates
  20. The infant gut microbiota: in pursuit of non-protein nitrogen
  21. Whey-based diet containing medium chain triglycerides modulates the gut microbiota and protects the intestinal mucosa from chemotherapy while maintaining therapy efficacy
  22. Enhanced stress resistance of Bifidobacterium breve NRBB57 by induction of stress proteins at near-zero growth rates
  23. Prenatal diet, plasma micronutrients/metabolome and inflammatory status influence the development of atopic eczema in early childhood
  24. Proof of principle study replicating microbial clusters in connection to birth mode and diet in the early life intestine
  25. Assessment of infant outgrowth of cow’s milk allergy in relation to the faecal microbiome and metaproteome
  26. Altered gut microbiome diversity and function in patients with propionic acidemia
  27. Quantitative physiology and proteome adaptations of Bifidobacterium breve NRBB57 at near-zero growth rates
  28. The Role of the Gut Microbiota in the Effects of Early-Life Stress and Dietary Fatty Acids on Later-Life Central and Metabolic Outcomes in Mice
  29. Early-life fecal microbiome and metabolome dynamics in response to an intervention with infant formula containing specific prebiotics and postbiotics
  30. Effect of antibiotics in the first week of life on faecal microbiota development
  31. Evaluation of Stool Short Chain Fatty Acids Profiles in the First Year of Life With Childhood Atopy-Related Outcomes
  32. Preventive Effect of a Postbiotic and Prebiotic Mixture in a Rat Model of Early Life Rotavirus Induced-Diarrhea
  33. Tolerance development in cow’s milk–allergic infants receiving amino acid–based formula: A randomized controlled trial
  34. The first fungi: mode of delivery determines early life fungal colonization in the intestine of preterm infants
  35. Influence of timing of maternal antibiotic administration during caesarean section on infant microbial colonisation: a randomised controlled trial
  36. The role of the gut microbiota in the effects of early-life stress and dietary fatty acids on later-life central and metabolic outcomes in mice
  37. Early-Life Respiratory Infections in Infants with Cow’s Milk Allergy: An Expert Opinion on the Available Evidence and Recommendations for Future Research
  38. From Mum to Bum: An Observational Study Protocol to Follow Digestion of Human Milk Oligosaccharides and Glycoproteins from Mother to Preterm Infant
  39. Ligilactobacillus salivarius PS2 Supplementation during Pregnancy and Lactation Prevents Mastitis: A Randomised Controlled Trial
  40. Effects of a Postbiotic and Prebiotic Mixture on Suckling Rats’ Microbiota and Immunity
  41. Household environmental microbiota influences early‐life eczema development
  42. A synbiotic intervention modulates meta-omics signatures of gut redox potential and acidity in elective caesarean born infants
  43. A Continuous Battle for Host-Derived Glycans Between a Mucus Specialist and a Glycan Generalist in vitro and in vivo
  44. Maturation of the preterm gastrointestinal tract can be defined by host and microbial markers for digestion and barrier defense
  45. Microbial Glycoside Hydrolases in the First Year of Life: An Analysis Review on Their Presence and Importance in Infant Gut
  46. Broad Purpose Vector for Site-Directed Insertional Mutagenesis in Bifidobacterium breve
  47. Early life antibiotics and childhood gastrointestinal disorders: a systematic review
  48. Fermented infant formula (with Bifidobacterium breve C50 and Streptococcus thermophilus O65) with prebiotic oligosaccharides is safe and modulates the gut microbiota towards a microbiota closer to that of breastfed infants
  49. Cross-feeding betweenBifidobacterium infantisandAnaerostipes caccaeon lactose and human milk oligosaccharides
  50. Impact of synbiotics on gut microbiota during early life: a randomized, double-blind study
  51. Breast milk urea as a nitrogen source for urease positiveBifidobacterium infantis
  52. Bifidobacterium Transformation
  53. Gut Microbiota of Young Children Living in Four Brazilian Cities
  54. The Bifidogenic Effect Revisited—Ecology and Health Perspectives of Bifidobacterial Colonization in Early Life
  55. Dietary patterns in childhood and their effect on gut microbiota—an Asian perspective on atopy risk
  56. A compromised developmental trajectory of the infant gut microbiome and metabolome in atopic eczema
  57. Bacteroides thetaiotaomicron Fosters the Growth of Butyrate-Producing Anaerostipes caccae in the Presence of Lactose and Total Human Milk Carbohydrates
  58. Enduring Behavioral Effects Induced by Birth by Caesarean Section in the Mouse
  59. Akkermansia muciniphila uses human milk oligosaccharides to thrive in the early life conditions in vitro
  60. The Infant-Derived Bifidobacterium bifidum Strain CNCM I-4319 Strengthens Gut Functionality
  61. Dynamics of the bacterial gut microbiota in preterm and term infants after intravenous amoxicillin/ceftazidime treatment
  62. Strain-Specific Probiotic Properties of Bifidobacteria and Lactobacilli for the Prevention of Diarrhea Caused by Rotavirus in a Preclinical Model
  63. The Influence of Timing of Maternal Administration of Antibiotics During Caesarean Section on the Intestinal Microbial Colonization in Infants (MAMI-Trial): A Randomized Controlled Trial
  64. Correction: Supplementation of diet with non-digestible oligosaccharides alters the intestinal microbiota, but not arthritis development, in IL-1 receptor antagonist deficient mice
  65. Microbial transmission from mother to child: improving infant intestinal microbiota development by identifying the obstacles
  66. Low‐calcium diet in mice leads to reduced gut colonization by Enterococcus faecium
  67. Postbiotics and Their Potential Applications in Early Life Nutrition and Beyond
  68. Oligosaccharides Modulate Rotavirus-Associated Dysbiosis and TLR Gene Expression in Neonatal Rats
  69. Short‐term changes of intestinal microbiota composition in preterm infants after two prophylactic doses of vancomycin
  70. Supplementation of diet with non-digestible oligosaccharides alters the intestinal microbiota, but not arthritis development, in IL-1 receptor antagonist deficient mice
  71. A specific synbiotic-containing amino acid-based formula restores gut microbiota in non-IgE mediated cow’s milk allergic infants: a randomized controlled trial
  72. Gut microbiota from infant with cow’s milk allergy promotes clinical and immune features of atopy in a murine model
  73. Prebiotic oligosaccharides in early life alter gut microbiome development in male mice while supporting influenza vaccination responses
  74. The Preterm Gut Microbiota: An Inconspicuous Challenge in Nutritional Neonatal Care
  75. Metaproteomic and 16S rRNA Gene Sequencing Analysis of the Infant Fecal Microbiome
  76. Supplementation of dietary non-digestible oligosaccharides from birth onwards improve social and reduce anxiety-like behaviour in male BALB/c mice
  77. Mice co-administrated with partially hydrolysed whey proteins and prebiotic fibre mixtures show allergen-specific tolerance and a modulated gut microbiota
  78. Prevention of Rotavirus Diarrhea in Suckling Rats by a Specific Fermented Milk Concentrate with Prebiotic Mixture
  79. A specific synbiotic-containing amino acid-based formula in dietary management of cow’s milk allergy: a randomized controlled trial
  80. The potential for pre-, pro- and synbiotics in the management of infants at risk of cow's milk allergy or with cow's milk allergy: An exploration of the rationale, available evidence and remaining questions
  81. Targeting the gut microbiota to influence brain development and function in early life
  82. The potential role of gut microbiota and its modulators in the management of propionic and methylmalonic acidemia
  83. Sex differences in lipid metabolism are affected by presence of the gut microbiota
  84. Comparative genomics and genotype-phenotype associations in Bifidobacterium breve
  85. A synbiotic mixture of scGOS/lcFOS and Bifidobacterium breve M-16V increases faecal Bifidobacterium in healthy young children
  86. Preventive Effect of a Synbiotic Combination of Galacto- and Fructooligosaccharides Mixture With Bifidobacterium breve M-16V in a Model of Multiple Rotavirus Infections
  87. Cross-feeding between Bifidobacterium infantis and Anaerostipes caccae on lactose and human milk oligosaccharides
  88. Intestinal microbiota in infants at high risk for allergy: Effects of prebiotics and role in eczema development
  89. Specific synbiotics in early life protect against diet-induced obesity in adult mice
  90. Deciphering the trophic interaction between Akkermansia muciniphila and the butyrogenic gut commensal Anaerostipes caccae using a metatranscriptomic approach
  91. Association between duration of intravenous antibiotic administration and early-life microbiota development in late-preterm infants
  92. Comparative genome and methylome analysis reveals restriction/modification system diversity in the gut commensal Bifidobacterium breve
  93. A synbiotic-containing amino-acid-based formula improves gut microbiota in non-IgE-mediated allergic infants
  94. Ratio of Klebsiella/Bifidobacterium in early life correlates with later development of paediatric allergy
  95. Microbial Metabolic Networks at the Mucus Layer Lead to Diet-Independent Butyrate and Vitamin B12 Production by Intestinal Symbionts
  96. P35: AMINO ACID-BASED FORMULA WITH SYNBIOTICS MODIFIES GUT MICROBIOTA IN NON-IGE MEDIATED COW’S MILK ALLERGIC INFANTS
  97. Metaproteomics reveals functional differences in intestinal microbiota development of preterm infants
  98. Effect of Synbiotic on the Gut Microbiota of Cesarean Delivered Infants
  99. Aberrant intestinal microbiota due to IL-1 receptor antagonist deficiency promotes IL-17- and TLR4-dependent arthritis
  100. Intervention strategies for cesarean section–induced alterations in the microbiota-gut-brain axis
  101. Early-life origin of intestinal inflammatory disorders
  102. Gut Microbiota Composition of Non-IgE Mediated Cow's Milk Allergic Infants before and after Dietary Management with a Synbiotics-Supplemented Amino Acid-Based Formula
  103. A fermented milk concentrate and a combination of short-chain galacto-oligosaccharides/long-chain fructo-oligosaccharides/pectin-derived acidic oligosaccharides protect suckling rats from rotavirus gastroenteritis
  104. Longitudinal Investigation of Carriage Rates, Counts, and Genotypes of Toxigenic Clostridium difficile in Early Infancy
  105. Human gut microbes impact host serum metabolome and insulin sensitivity
  106. Early-Life Events, Including Mode of Delivery and Type of Feeding, Siblings and Gender, Shape the Developing Gut Microbiota
  107. The Variable Regions ofLactobacillus rhamnosusGenomes Reveal the Dynamic Evolution of Metabolic and Host-Adaptation Repertoires
  108. A combination of scGOS/lcFOS with Bifidobacterium breve M-16V protects suckling rats from rotavirus gastroenteritis
  109. Gut Microbiota Dysbiosis as Risk and Premorbid Factors of IBD and IBS Along the Childhood–Adulthood Transition
  110. Infant formula containing galacto-and fructo-oligosaccharides and Bifidobacterium breve M-16V supports adequate growth and tolerance in healthy infants in a randomised, controlled, double-blind, prospective, multicentre study
  111. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota
  112. The Gut Microbiota as a Therapeutic Target in IBD and Metabolic Disease: A Role for the Bile Acid Receptors FXR and TGR5
  113. Multilocus sequence typing of bifidobacterial strains from infant’s faeces and human milk: are bifidobacteria being sustainably shared during breastfeeding?
  114. Similar Occurrence of Febrile Episodes Reported in Non-Atopic Children at Three to Five Years of Age after Prebiotics Supplemented Infant Formula
  115. Carbohydrate utilization genetic signatures in the species Lactobacillus rhamnosus
  116. Fermented Infant Formula Increases Ileal Protein Digestibility and Reduces Ileal Proteolytic Activity Compared with Standard and Hydrolyzed Infant Formulas in Piglets
  117. Preweaning modulation of intestinal microbiota by oligosaccharides or amoxicillin can contribute to programming of adult microbiota in rats
  118. Dietary Pectin–Derived Acidic Oligosaccharides Improve the Pulmonary Bacterial Clearance ofPseudomonas aeruginosaLung Infection in Mice by Modulating Intestinal Microbiota and Immunity
  119. An integrated catalog of reference genes in the human gut microbiome
  120. Identification and assembly of genomes and genetic elements in complex metagenomic samples without using reference genomes
  121. The first thousand days - intestinal microbiology of early life: establishing a symbiosis
  122. Altered gut microbiota and activity in a murine model of autism spectrum disorders
  123. Mother-to-Infant Transmission of Intestinal Bifidobacterial Strains Has an Impact on the Early Development of Vaginally Delivered Infant's Microbiota
  124. A novel protein mixture containing vegetable proteins renders enteral nutrition products non-coagulating after in vitro gastric digestion
  125. Richness of human gut microbiome correlates with metabolic markers
  126. Relevance of pre- and postnatal nutrition to development and interplay between the microbiota and metabolic and immune systems
  127. Intestinal microbiology in early life: specific prebiotics can have similar functionalities as human-milk oligosaccharides
  128. The Immunomodulatory Nutritional Intervention NR100157 Reduced CD4+ T-Cell Decline and Immune Activation: A 1-Year Multicenter Randomized Controlled Double-Blind Trial in HIV-Infected Persons Not Receiving Antiretroviral Therapy (The BITE Study)
  129. Human milk: a source of more life than we imagine
  130. Influence of fermented milk products, prebiotics and probiotics on microbiota composition and health
  131. Development of the Digestive System—Experimental Challenges and Approaches of Infant Lipid Digestion
  132. The effect of enteral supplementation of specific neutral and acidic oligosaccharides on the faecal microbiota and intestinal microenvironment in preterm infants
  133. Structure and Catalytic Mechanism of 3-Ketosteroid-Δ4-(5α)-dehydrogenase fromRhodococcus jostiiRHA1 Genome
  134. The Early Settlers: Intestinal Microbiology in Early Life
  135. Improved Detection of Bifidobacteria with Optimised 16S rRNA-Gene Based Pyrosequencing
  136. Galectin-9 induced by dietary synbiotics is involved in suppression of allergic symptoms in mice and humans
  137. A Fermented Infant Milk Formula Reduces Ileal Proteolytic Activity
  138. Effects of a New Prebiotic Mixture on Faecal Gut Microbiota and the Mucosal Immune System in Healthy Infants
  139. Cloning, overexpression, purification, crystallization and preliminary X-ray analysis of 3-ketosteroid Δ4-(5α)-dehydrogenase fromRhodococcus jostiiRHA1
  140. Analysis of infant isolates of Bifidobacterium breve by comparative genome hybridization indicates the existence of new subspecies with marked infant specificity
  141. Transmission of Intestinal Bifidobacterium longum subsp.longumStrains from Mother to Infant, Determined by Multilocus Sequencing Typing and Amplified Fragment Length Polymorphism
  142. Bifidobacterium breve– HT-29 cell line interaction: modulation of TNF-α induced gene expression
  143. Bacterial Translocation Is Reduced by a Specific Nutritional Combination in Mice with Chemotherapy-Induced Neutropenia
  144. Specific prebiotics modulate gut microbiota and immune activation in HAART-naive HIV-infected adults: results of the “COPA” pilot randomized trial
  145. Enterotypes of the human gut microbiome
  146. Early life: gut microbiota and immune development in infancy
  147. 89 The Effect of Enteral Supplementation of Neutral and Acidic Oligosaccharides on Intestinal Microbiota, Ph, Scfas and Siga in Preterm Infants
  148. Bifidobacterium population analysis in the infant gut by direct mapping of genomic hybridization patterns: potential for monitoring temporal development and effects of dietary regimens
  149. Molecular analysis of faecal and duodenal samples reveals significantly higher prevalence and numbers of Pseudomonas aeruginosa in irritable bowel syndrome
  150. Metagenomics of the intestinal microbiota: potential applications
  151. Tolerance and safety of the potentially probiotic strain Lactobacillus rhamnosus PRSF-L477: a randomised, double-blind placebo-controlled trial in healthy volunteers
  152. Effect of multifibre mixture with prebiotic components on bifidobacteria and stool pH in tube-fed children
  153. Intestinal microbiota in allergic and nonallergic 1-year-old very low birth weight infants after neonatal glutamine supplementation
  154. Specific prebiotic oligosaccharides modulate the early phase of a murine vaccination response
  155. Gut health: predictive biomarkers for preventive medicine and development of functional foods
  156. A human gut microbial gene catalogue established by metagenomic sequencing
  157. Effect of a new synbiotic mixture on atopic dermatitis in infants: a randomized-controlled trial
  158. Exposure of Intestinal Epithelial Cells to UV-Killed Lactobacillus GG but Not Bifidobacterium breve Enhances the Effector Immune Response in vitro
  159. Oral Treatment with Probiotics Reduces Allergic Symptoms in Ovalbumin-Sensitized Mice: A Bacterial Strain Comparative Study
  160. Prebiotics and Probiotics in Infant Formulae
  161. Cow Milk Allergy Symptoms Are Reduced in Mice Fed Dietary Synbiotics during Oral Sensitization with Whey
  162. Mixed-Species Genomic Microarray Analysis of Fecal Samples Reveals Differential Transcriptional Responses of Bifidobacteria in Breast- and Formula-Fed Infants
  163. Lower Bifidobacteria counts in both duodenal mucosa-associated and fecal microbiota in irritable bowel syndrome patients
  164. Fecal Secretory Immunoglobulin A Is Increased in Healthy Infants Who Receive a Formula with Short-Chain Galacto-Oligosaccharides and Long-Chain Fructo-Oligosaccharides
  165. 3-Keto-5α-steroid Δ1-dehydrogenase fromRhodococcus erythropolisSQ1 and its orthologue inMycobacterium tuberculosisH37Rv are highly specific enzymes that function in cholesterol catabolism
  166. Prebiotic oligosaccharides and the enterohepatic circulation of bile salts in rats
  167. Biosafety assessment of probiotics used for human consumption: recommendations from the EU-PROSAFE project
  168. Carbohydrates in Human Milk and Infant Formulas
  169. Early Impairment of Gut Function and Gut Flora Supporting a Role for Alteration of Gastrointestinal Mucosa in Human Immunodeficiency Virus Pathogenesis
  170. Effects of galactooligosaccharide and long-chain fructooligosaccharide supplementation during pregnancy on maternal and neonatal microbiota and immunity—a randomized, double-blind, placebo-controlled study
  171. The effect of glutamine-enriched enteral nutrition on intestinal microflora in very low birth weight infants: A randomized controlled trial
  172. Dietary supplementation of neutral and acidic oligosaccharides enhances Th1‐dependent vaccination responses in mice
  173. Increase of faecal bifidobacteria due to dietary oligosaccharides induces a reduction of clinically relevant pathogen germs in the faeces of formula-fed preterm infants
  174. A specific prebiotic oligosaccharide mixture stimulates delayed-type hypersensitivity in a murine influenza vaccination model
  175. The intestinal bacterial colonisation in preterm infants: A review of the literature
  176. Transcriptome Analysis Reveals Mechanisms by Which Lactococcus lactis Acquires Nisin Resistance
  177. Bifidogenic Effects of Solid Weaning Foods With Added Prebiotic Oligosaccharides
  178. Quantitative Real-Time PCR Analysis of Fecal Lactobacillus Species in Infants Receiving a Prebiotic Infant Formula
  179. Effects of total enteral nutrition supplemented with a multi-fibre mix on faecal short-chain fatty acids and microbiota
  180. Effects of infant formula containing a mixture of galacto- and fructo-oligosaccharides or viable Bifidobacterium animalis on the intestinal microflora during the first 4 months of life
  181. Galacto-oligosaccharides and long-chain fructo-oligosaccharides as prebiotics in infant formulas: A review
  182. Increase of faecal bifidobacteria due to dietary oligosaccharides induces a reduction of clinically relevant pathogen germs in the faeces of formula-fed preterm infants
  183. Prebiotic carbohydrates in human milk and formulas
  184. Strain-Specific Effects of Probiotics on Gut Barrier Integrity following Hemorrhagic Shock
  185. Quantitative Real-Time PCR Assays To Identify and Quantify Fecal Bifidobacterium Species in Infants Receiving a Prebiotic Infant Formula
  186. The gusBC Genes of Escherichia coli Encode a Glucuronide Transport System
  187. Colon Microflora in Infants Fed Formula with Galacto- and Fructo-Oligosaccharides: More Like Breast-Fed Infants
  188. 134 Effect of Colonic Short Chain Fatty Acids, Lactate and PH on The Growth of Common Gut Pathogens
  189. Prebiotics in Infant Formulas
  190. Prebiotics and Immune Responses
  191. Randomized Double-Blind Study of the Nutritional Efficacy and Bifidogenicity of a New Infant Formula Containing Partially Hydrolyzed Protein, a High β-Palmitic Acid Level, and Nondigestible Oligosaccharides
  192. Development of 16S rRNA-Based Probes for theCoriobacterium Group and the Atopobium Cluster and Their Application for Enumeration of Coriobacteriaceaein Human Feces from Volunteers of Different Age Groups
  193. Rotational Mobility and Orientational Stability of a Transport Protein in Lipid Membranes
  194. Quaternary Structure of the Lactose Transport Protein ofStreptococcus thermophilusin the Detergent-solubilized and Membrane-reconstituted State
  195. Close Approximation of Putative α-Helices II, IV, VII, X, and XI in the Translocation Pathway of the Lactose Transport Protein ofStreptococcus thermophilus
  196. Amplified expression and membrane reconstitution of transport proteins
  197. Detergent-Mediated Reconstitution of Membrane Proteins†
  198. Amplified Expression, Purification and Functional Reconstitution of the Dipeptide and Tripeptide Transport Protein of Lactococcus Lactis
  199. Unidirectional Reconstitution into Detergent-destabilized Liposomes of the Purified Lactose Transport System ofStreptococcus thermophilus
  200. Cation and sugar selectivity determinants in a novel family of transport proteins
  201. Purification and Reconstitution of the Glutamate Carrier GltT of the Thermophilic Bacterium Bacillus stearothermophilus
  202. Kinetic Analysis of Lactose and Proton Coupling in Glu379Mutants of the Lactose Transport Protein ofStreptococcus thermophilus
  203. Regulation of bacterial sugar-H+ symport by phosphoenolpyruvate-dependent enzyme I/HPr-mediated phosphorylation.
  204. Directed genomic integration, gene replacement, and integrative gene expression in Streptococcus thermophilus
  205. A Kdp-like, high-affinity, K+-translocating ATPase is expressed during growth of Rhodobacter sphaeroides in low potassium media